Literature DB >> 17223438

Carcinoid heart disease in patients without hepatic metastases.

Alain M Bernheim1, Heidi M Connolly, Patricia A Pellikka.   

Abstract

Most carcinoid tumors originate in the gut. Carcinoid heart disease typically occurs when tumor progression results in the formation of hepatic metastases, which allow vasoactive substances to reach the heart without being metabolized in the liver. Except for patients with primary ovarian carcinoid tumors, the occurrence of carcinoid heart disease without hepatic metastases has been reported only anecdotally. From a retrospective analysis of 265 patients, 4 patients were identified who developed carcinoid heart disease in the absence of liver metastases or primary tumors located in the ovaries. All 4 patients had metastases to the retroperitoneal lymph nodes and had carcinoid syndrome. The reasons for referral to cardiac evaluation by transthoracic echocardiography were findings on auscultation in 3 patients and exertional dyspnea in 1 patient. In conclusion, cardiac symptoms or findings on auscultation should prompt further evaluation by transthoracic echocardiography in these patients, although the classic prerequisites for development of carcinoid heart disease are lacking.

Entities:  

Mesh:

Year:  2006        PMID: 17223438     DOI: 10.1016/j.amjcard.2006.07.092

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  Echocardiography in functional midgut neuroendocrine tumors: When and how often.

Authors:  Javier G Castillo; Tara Naib; Jerome S Zacks; David H Adams
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Ileal neuroendocrine tumors and heart: not only valvular consequences.

Authors:  Jan Calissendorff; Eva Maret; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2014-10-16       Impact factor: 3.633

3.  Carcinoid valve disease.

Authors:  J Wells Askew; Heidi M Connolly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

4.  Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease.

Authors:  V Jahagirdar; Ali Kamal; R Steeds; John Ayuk
Journal:  BMJ Case Rep       Date:  2016-02-03

5.  ⁶⁸Ga-DOTA-TOC-PET/CT detects heart metastases from ileal neuroendocrine tumors.

Authors:  Jan Calissendorff; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

6.  Failing stentless Bioprostheses in patients with carcinoid heart valve disease.

Authors:  Andreas Schaefer; Bjoern Sill; Jeannette Schoenebeck; Yvonne Schneeberger; Hermann Reichenspurner; Helmut Gulbins
Journal:  J Cardiothorac Surg       Date:  2015-03-27       Impact factor: 1.637

Review 7.  Complications from carcinoid syndrome: review of the current evidence.

Authors:  José Mauricio Mota; Luana Guimarães Sousa; Rachel P Riechelmann
Journal:  Ecancermedicalscience       Date:  2016-08-08

8.  Primary adenocarcinoma of the lung with a synchronous carcinoid tumour of the small intestine.

Authors:  Lola Loewenthal; Mary Thompson; Sarah L Elkin
Journal:  JRSM Short Rep       Date:  2013-03-06

9.  Tricuspid valve regurgitation as a presenting symptom of metastasized carcinoid tumor.

Authors:  Anton F Engelsman; Peter van Duijvendijk; Bjorn E Groenemeijer; Edwin van der Zaag; Peter E Spronk; Alex Katinakis
Journal:  Case Rep Gastroenterol       Date:  2012-09-29

10.  Carcinoid heart disease.

Authors:  Alain M Bernheim; Heidi M Connolly; Patricia A Pellikka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.